Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Murray

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Virology|August 7, 2008
A critical role for CD63 in HIV replication and infection of macrophages and cell linesHui Chen, Natallia Dziuba, Brian Friedrich, et al.
Traffic (Copenhagen, Denmark)|March 16, 2006
Internalized Pseudomonas exotoxin A can exploit multiple pathways to reach the endoplasmic reticulumDaniel C Smith, Robert A Spooner, Peter D Watson, et al.
Breast Cancer Research and Treatment|March 27, 2013
Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancerJames L Murray, Patricia Thompson, Suk Young Yoo, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 13, 2002
Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breastHenry M Kuerer, George E Peoples, Aysegul A Sahin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2012
Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotypeRichard C Wu, Shujuan Liu, Jessica A Chacon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Induction of tumor-reactive CTL by C-side chain variants of the CTL epitope HER-2/neu protooncogene (369-377) selected by molecular modeling of the peptide: HLA-A2 complexAgapito Castilleja, Darrick Carter, Clay L Efferson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Relationship between epidemiologic risk factors and breast cancer recurrenceAbenaa M Brewster, Kim-Anh Do, Patricia A Thompson, et al.
Virology|April 15, 2014
Nuclear trafficking of the HIV-1 pre-integration complex depends on the ADAM10 intracellular domainMark A Endsley, Anoma D Somasunderam, Guangyu Li, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancerFrancisco J Esteva, Stacy L Moulder, Ana M Gonzalez-Angulo, et al.
Oncotarget|September 3, 2016
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrenceElizabeth A Mittendorf, Alexandros Ardavanis, Jennifer K Litton, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Virology|August 7, 2008
A critical role for CD63 in HIV replication and infection of macrophages and cell linesHui Chen, Natallia Dziuba, Brian Friedrich, et al.
Traffic (Copenhagen, Denmark)|March 16, 2006
Internalized Pseudomonas exotoxin A can exploit multiple pathways to reach the endoplasmic reticulumDaniel C Smith, Robert A Spooner, Peter D Watson, et al.
Breast Cancer Research and Treatment|March 27, 2013
Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancerJames L Murray, Patricia Thompson, Suk Young Yoo, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 13, 2002
Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breastHenry M Kuerer, George E Peoples, Aysegul A Sahin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2012
Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotypeRichard C Wu, Shujuan Liu, Jessica A Chacon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 24, 2002
Induction of tumor-reactive CTL by C-side chain variants of the CTL epitope HER-2/neu protooncogene (369-377) selected by molecular modeling of the peptide: HLA-A2 complexAgapito Castilleja, Darrick Carter, Clay L Efferson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 6, 2007
Relationship between epidemiologic risk factors and breast cancer recurrenceAbenaa M Brewster, Kim-Anh Do, Patricia A Thompson, et al.
Virology|April 15, 2014
Nuclear trafficking of the HIV-1 pre-integration complex depends on the ADAM10 intracellular domainMark A Endsley, Anoma D Somasunderam, Guangyu Li, et al.
Cancer Chemotherapy and Pharmacology|October 12, 2012
Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancerFrancisco J Esteva, Stacy L Moulder, Ana M Gonzalez-Angulo, et al.
Oncotarget|September 3, 2016
Primary analysis of a prospective, randomized, single-blinded phase II trial evaluating the HER2 peptide GP2 vaccine in breast cancer patients to prevent recurrenceElizabeth A Mittendorf, Alexandros Ardavanis, Jennifer K Litton, et al.
Pageof 7